Archon Capital Management’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-260,858
| Closed | -$1.11M | – | 25 |
|
|
2024
Q1 | $1.11M | Sell |
260,858
-18,500
| -7% | -$78.4K | 0.38% | 29 |
|
|
2023
Q4 | $1.49M | Hold |
279,358
| – | – | 0.37% | 28 |
|
|
2023
Q3 | $1.2M | Hold |
279,358
| – | – | 0.32% | 30 |
|
|
2023
Q2 | $1.53M | Sell |
279,358
-1,082,411
| -79% | -$5.94M | 0.32% | 26 |
|
|
2023
Q1 | $5.72M | Hold |
1,361,769
| – | – | 1.28% | 20 |
|
|
2022
Q4 | $3.77M | Buy |
1,361,769
+56,244
| +4% | +$156K | 1.1% | 21 |
|
|
2022
Q3 | $3.34M | Buy |
1,305,525
+349,049
| +36% | +$894K | 0.59% | 23 |
|
|
2022
Q2 | $3.44M | Buy |
956,476
+270,240
| +39% | +$973K | 0.79% | 23 |
|
|
2022
Q1 | $4.26M | Hold |
686,236
| – | – | 0.53% | 21 |
|
|
2021
Q4 | $4.84M | Sell |
686,236
-50,000
| -7% | -$353K | 0.64% | 20 |
|
|
2021
Q3 | $5.14M | Sell |
736,236
-8,783
| -1% | -$61.3K | 0.73% | 23 |
|
|
2021
Q2 | $6.21M | Sell |
745,019
-136,775
| -16% | -$1.14M | 0.7% | 21 |
|
|
2021
Q1 | $4.82M | Hold |
881,794
| – | – | 0.69% | 23 |
|
|
2020
Q4 | $3.78M | Hold |
881,794
| – | – | 0.65% | 21 |
|
|
2020
Q3 | $2.65M | Buy |
881,794
+63,746
| +8% | +$192K | 0.53% | 23 |
|
|
2020
Q2 | $2.54M | Buy |
+818,048
| New | +$2.54M | 0.54% | 26 |
|